Can SARS-CoV-2 screening in oral biopsies aid epidemiological surveillance?
Roberta Rayra Martins-ChavesMarina Gonçalves DinizLucyene MiguitaFernanda Aragão FelixFernanda Faria RochaPaula Luize Camargos FonsecaVictor Emmanuel Viana GeddesDiego MenezesRennan Garcias MoreiraTatiana Liborio-KimuraJeconias CâmaraTássia Caroline da Costa MendesHelder Antonio Rebelo PontesFlavia Sirotheau Correa PontesThayanne Oliveira de Freitas GonçalvesThamyres Campos FonsêcaAline Corrêa AbrahãoMário José RomañachAna Paula Negreiros Nunes AlvesKaruza Maria Alves PereiraDanyel Elias da Cruz PerezElaine Judite de Amorim CarvalhoJean Nunes Dos SantosFlávia Caló de Aquino XavierFernando Costa GiffoniAlessandra Hubner de SouzaCarolina Cavaliéri GomesSílvia Ferreira de SousaFlávia Sirotheau Correa PontesRenan Pedra de SouzaRenato Santana AguiarRicardo Santiago GomezPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2023)
Although our approach did not value aiding asymptomatic epidemiological surveillance, we could successfully identify a using FFPE tissue samples. Therefore, we suggest using FFPE tissue samples from patients who have confirmed diagnosis of SARS-CoV-2 infection for phylogenetic reconstruction and contraindicate the routine laboratory screening of these samples as a tool for asymptomatic epidemiological surveillance.